EUTM file information

001732957

GELTEX


June 29, 2000

Trademark Summary

The trademark GELTEX was filed by Genzyme Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on February 11, 2001, and received one opposition filed on March 29, 2001 by GUARRO CASAS, S.A. on Likelihood of confusion. the opponent was represented by PONTI & PARTNERS, S.L.P and proceedings were handled in French, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 29, 2001

The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).

The renewal of the trademark was recorded by the office on April 30, 2011.

of the trademark registration was recorded on April 30, 2011. A transfer of the trademark registration was recorded on May 28, 2007. Change of name and professional address of the trademark registration was recorded on July 8, 2007. Change of name and professional address of the trademark registration was recorded on January 11, 2009. Change of name and address of the trademark registration was recorded on September 1, 2011.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical, veterinary and sanitary preparations
    2. Pharmaceuticals for the treatment of disease
    3. Dietetic substances adapted for medical use
    4. Food for babies
    5. Plasters, materials for dressings
    6. Material for stopping teeth
    7. Dental wax
    8. Disinfectants
    9. Preparations for destroying vermin
    10. Fungicides, herbicides.
  • The mark was filed in class 16 with Printed matter relating to science, medicine and pharmacy.
  • The mark was filed in class 42 with following description of goods:
    1. Research, design and consultancy services relating to science and medicine
    2. Providing scientific and medical research services
    3. Providing information in the field of science and medicine.